Opioid Antagonists

As part of the search for a “magic bullet,” scientists developed a number of heroin antagonists, substances that block or counteract the effects of opiates. These substances bind with opiate receptor sites, thereby preventing stimulation, or they displace an opiate that is already at the site. Antagonists, such as naloxone (Narcan), have significant side effects.

A dose as small as 0.25 mg will block the effects of heroin for ten hours, but it is effective only when administered intravenously. It does not reduce the “drug hunger” of heroin addicts. Naloxone is used for testing for opiate dependence (Narcon test) before admission to a methadone program.

Naloxone is administered to people seeking methadone treatment because they might not be opioid-dependent or might have only minimal dependence. Their admission to a methadone program would raise ethical and legal questions since methadone is addicting. According to federal regulations, admission to methadone treatment is restricted to people who have been addicted to heroin for at least one year.

Like any antagonist, naltrexone is effective only with patients who are motivated to give up the feeling of euphoria that opiates can provide. The manufacturer clearly states that it is recommended for use as an adjunct in the treatment of opioid abusers. Treatment failure cannot be blamed on the failure of naltrexone to block opioids nor is treatment success likely to be the consequence of a use of naltrexone alone. Some antagonist artist are likely being hate by society, as heroes and romantic artists are being popular. The popularity itself are infected to wedding photography with some heroes or romantic theme, they made wedding photograph or hochzeitsfotograf frankfurt as their memorable moment.

In 1995 the Food and Drug Administration (FDA) approved naltrexone to prevent alcohol relapse by alcohol-dependent patients, and under the brand names ReVia and Depade, naltrexone is marketed for use in treating alcoholism. Alcohol causes the release of endorphins, which are believed a major factor in causing a person to continue drinking. Naltrexone blocks the endorphin-mediated rewarding effects of drinking alcohol thereby reducing craving.